04/01/2024
6:06 AM | Autolus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
3:10 PM | Autolus Therapeutics (Subject)
Kellnerova Renata (Filed by)
| Form SC 13D/A | |
03/21/2024
3:21 PM | Autolus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/15/2024
3:21 PM | Autolus Therapeutics (Filer)
| Form 8-K/A | |
03/14/2024
11:32 AM | Autolus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/23/2024
4:28 PM | Autolus Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
02/14/2024
1:41 PM | ARMISTICE CAPITAL, LLC (Filed by)
Autolus Therapeutics (Subject)
| Form SC 13G/A | |
|
02/14/2024
7:37 AM | Autolus Therapeutics (Subject)
Deep Track Capital, LP (Filed by)
| Form SC 13G/A | |
02/13/2024
5:41 PM | Autolus Therapeutics (Subject)
Syncona Portfolio Ltd (Filed by)
| Form SC 13G/A | |
02/09/2024
4:15 PM | Autolus Therapeutics (Filer)
| Form 424B5 | |
02/08/2024
3:17 PM | Autolus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2024
9:00 PM | Autolus Therapeutics (Filer)
| Form S-3ASR | |
02/08/2024
5:06 AM | Autolus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/31/2024
3:10 PM | Autolus Therapeutics (Subject)
Tetragon Financial Management LP (Filed by)
| Form SC 13G/A | |
01/26/2024
12:02 PM | Autolus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2024
2:12 PM | Autolus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/22/2023
7:24 AM | Autolus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/11/2023
7:31 AM | Autolus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/27/2023
6:07 AM | Autolus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
8:18 AM | Autolus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/02/2023
3:26 PM | Autolus Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/03/2023
3:32 PM | Autolus Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/21/2023
3:07 PM | Autolus Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/10/2023
4:00 PM | Autolus Therapeutics (Subject)
Paradigm Biocapital Advisors LP (Filed by)
| Form SC 13G | |
07/06/2023
3:29 PM | Autolus Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/06/2023
7:18 AM | Autolus Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/06/2023
7:11 AM | Autolus Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
